Rainbow Children's Medicare Ltd

₹ 747 -1.76%
07 Dec - close price
About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology.[1]

Key Points

Infrastructure:[1] RCML operates 14 hospitals and 3 clinics, 5 of which are NABH-accredited and 3 of which have received EDGE certification spread across the cities of Telangana, Andhra Pradesh, Karnataka, and Tamil Nadu.

  • Market Cap 7,581 Cr.
  • Current Price 747
  • High / Low 886 / 410
  • Stock P/E 48.5
  • Book Value 93.2
  • Dividend Yield 0.27 %
  • ROCE 22.6 %
  • ROE 26.3 %
  • Face Value 10.0

Pros

  • Debtor days have improved from 20.7 to 15.2 days.

Cons

  • Stock is trading at 8.01 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
164 246 266 249 212 237 313
132 168 177 159 164 155 204
Operating Profit 32 78 89 89 48 82 110
OPM % 20% 32% 34% 36% 23% 35% 35%
2 2 5 6 6 6 8
Interest 13 13 12 12 16 14 13
Depreciation 20 19 21 21 22 22 22
Profit before tax 2 48 61 62 16 52 81
Tax % 30% 25% 26% 27% 22% 25% 24%
Net Profit 1 36 45 45 12 39 62
EPS in Rs 0.29 8.17 10.28 4.78 1.30 3.76 6.02
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
543 719 650 974 1,011
391 519 485 666 682
Operating Profit 151 201 165 308 329
OPM % 28% 28% 25% 32% 33%
8 10 10 19 25
Interest 42 48 46 56 55
Depreciation 60 69 73 83 88
Profit before tax 58 93 56 187 211
Tax % 22% 41% 29% 26%
Net Profit 45 55 40 139 158
EPS in Rs 10.14 12.68 9.10 14.70 15.86
Dividend Payout % 10% 16% -0% 14%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 22%
TTM: 50%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 46%
TTM: 249%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 17%
Last Year: 26%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
55 55 55 105 102
Reserves 317 350 391 498 845
465 490 518 581 558
100 134 127 123 132
Total Liabilities 926 1,019 1,081 1,296 1,636
702 702 772 858 879
CWIP 23 43 29 6 29
Investments 3 10 18 22 -0
199 265 262 409 729
Total Assets 926 1,019 1,081 1,296 1,636

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
127 170 143 224
-117 -117 -83 -175
-9 -52 -61 -44
Net Cash Flow 2 2 -1 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 24 22 25 15
Inventory Days 32 55 36 28
Days Payable 197 202 190 121
Cash Conversion Cycle -141 -124 -130 -78
Working Capital Days -20 -6 -9 -7
ROCE % 16% 11% 23%

Shareholding Pattern

Numbers in percentages

16 recently
Jun 2022 Sep 2022
49.83 49.83
22.97 15.89
9.44 10.25
17.76 24.02

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents